|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61P 3/06 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 1355644 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02709050.5 |
| Date of filing the European patent application | 2002-01-25 | |
| (97) | Date of publication of the European application | 2003-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2006-06-28 |
| (46) | Date of publication of the claims translation | 2006-11-27 |
| (86) | Number | PCT/US2002/001195 |
| Date | 2002-01-25 |
| (87) | Number | WO 2002/058696 |
| Date | 2002-08-01 |
| (30) | Number | Date | Country code |
| 264645 P | 2001-01-26 | US |
| (72) |
DAVIS, Harry, R., US
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Pakeistų azetidinono junginių panaudojimas sitosterolemijos gydymui |
| THE USE OF SUBSTITUTED AZETIDINONE COMPOUNDS FOR THE TREATMENT OF SITOSTEROLEMIA |
| Payment date | Validity (years) | Amount | |
| 2021-01-12 | 347.00 EUR |